Sivik Global Healthcare’s Bio-Rad Laboratories Class A BIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.34M | Buy |
+18,000
| New | +$4.34M | 1.18% | 25 |
|
|
2025
Q1 | – | Sell |
-10,000
| Closed | -$3.29M | – | 33 |
|
|
2024
Q4 | $3.29M | Buy |
+10,000
| New | +$3.29M | 1.73% | 26 |
|
|
2021
Q2 | – | Sell |
-6,500
| Closed | -$3.71M | – | 50 |
|
|
2021
Q1 | $3.71M | Sell |
6,500
-1,500
| -19% | -$857K | 1.35% | 35 |
|
|
2020
Q4 | $4.66M | Buy |
8,000
+500
| +7% | +$292K | 1.9% | 30 |
|
|
2020
Q3 | $3.87M | Buy |
+7,500
| New | +$3.87M | 1.66% | 31 |
|
|
2020
Q1 | – | Sell |
-15,000
| Closed | -$5.55M | – | 43 |
|
|
2019
Q4 | $5.55M | Sell |
15,000
-3,000
| -17% | -$1.11M | 2.06% | 25 |
|
|
2019
Q3 | $5.99M | Buy |
18,000
+500
| +3% | +$166K | 3.02% | 12 |
|
|
2019
Q2 | $5.47M | Sell |
17,500
-2,500
| -13% | -$781K | 1.32% | 19 |
|
|
2019
Q1 | $6.11M | Buy |
20,000
+7,500
| +60% | +$2.29M | 2.25% | 13 |
|
|
2018
Q4 | $2.9M | Sell |
12,500
-7,500
| -38% | -$1.74M | 1.56% | 30 |
|
|
2018
Q3 | $6.26M | Buy |
20,000
+2,500
| +14% | +$783K | 2.23% | 18 |
|
|
2018
Q2 | $5.05M | Buy |
17,500
+2,500
| +17% | +$721K | 1.94% | 23 |
|
|
2018
Q1 | $3.75M | Buy |
15,000
+2,500
| +20% | +$625K | 1.75% | 25 |
|
|
2017
Q4 | $2.98M | Buy |
12,500
+2,500
| +25% | +$597K | 1.11% | 44 |
|
|
2017
Q3 | $2.22M | Buy |
+10,000
| New | +$2.22M | 0.76% | 51 |
|